Open Label Study To Assess The Effectiveness Of Amlodipin... | NCT00174304 | Trialant

Open Label Study To Assess The Effectiveness Of Amlodipin... | NCT00174304 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing percentage of subjects who reach target BP and LDL-C targets as defined by their governing guidelines.

Secondary Outcomes

Measure	Description	Time Frame
To asses changes since baseline of lab parameters, BP, safety of titration of amlodipine.atorvastatin to reach targets, to validate Expectations and Satisfaction with Treatment questionnaires.

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
19407658	Derived	Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM; JEWEL Study Group. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):472-80. doi: 10.1097/HJR.0b013e32832b63f5.